These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28664914)

  • 1. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
    Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
    Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression.
    McConnell BV; Koto K; Gutierrez-Hartmann A
    Mol Cancer; 2011 Jun; 10():75. PubMed ID: 21682918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.
    Niu Y; Shao Z; Wang H; Yang J; Zhang F; Luo Y; Xu L; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():26112. PubMed ID: 27181092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalanced LIMK1 and LIMK2 expression leads to human colorectal cancer progression and metastasis via promoting β-catenin nuclear translocation.
    Zhang Y; Li A; Shi J; Fang Y; Gu C; Cai J; Lin C; Zhao L; Liu S
    Cell Death Dis; 2018 Jul; 9(7):749. PubMed ID: 29970879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K Catalytic Isoform Alteration Promotes the LIMK1-related Metastasis Through the PAK1 or ROCK1/2 Activation in Cigarette Smoke-exposed Ovarian Cancer Cells.
    Park GB; Kim D
    Anticancer Res; 2017 Apr; 37(4):1805-1818. PubMed ID: 28373445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer.
    Su B; Su J; Zeng Y; Liu F; Xia H; Ma YH; Zhou ZG; Zhang S; Yang BM; Wu YH; Zeng X; Ai XH; Ling H; Jiang H; Su Q
    Oncotarget; 2016 Mar; 7(9):10498-512. PubMed ID: 26871290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the 14-3-3σ is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway.
    Shao Z; Cai Y; Xu L; Yao X; Shi J; Zhang F; Luo Y; Zheng K; Liu J; Deng F; Li R; Zhang L; Wang H; Li M; Ding Y; Zhao L
    Sci Rep; 2016 May; 6():25631. PubMed ID: 27156963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
    Hu J; Li G; Liu L; Wang Y; Li X; Gong J
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407.
    Tan X; Chen S; Wu J; Lin J; Pan C; Ying X; Pan Z; Qiu L; Liu R; Geng R; Huang W
    Cell Death Dis; 2017 Mar; 8(3):e2686. PubMed ID: 28300833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.
    Zhao GX; Xu YY; Weng SQ; Zhang S; Chen Y; Shen XZ; Dong L; Chen S
    Oncogene; 2019 Jun; 38(23):4574-4589. PubMed ID: 30742066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRX5 promotes colorectal cancer metastasis by negatively regulating the core components of the RHOA pathway.
    Zhu Q; Wu Y; Yang M; Wang Z; Zhang H; Jiang X; Chen M; Jin T; Wang T
    Mol Carcinog; 2019 Nov; 58(11):2065-2076. PubMed ID: 31432570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
    Zhou Y; Su J; Shi L; Liao Q; Su Q
    Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
    Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
    Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of intravenous anesthetics in colorectal cancer progression: implications for clinical application.
    Deng F; Ouyang M; Wang X; Yao X; Chen Y; Tao T; Sun X; Xu L; Tang J; Zhao L
    Oncotarget; 2016 Nov; 7(47):77087-77095. PubMed ID: 27780923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.